海南海药: 2025年半年度业绩预告

Performance Forecast - The company expects a net loss attributable to shareholders of between 120 million and 160 million yuan, compared to a loss of 200.31 million yuan in the same period last year [1] - The net loss after deducting non-recurring gains and losses is estimated to be between 140 million and 170 million yuan, compared to a loss of 153.07 million yuan in the previous year [1] - The basic earnings per share are projected to be a loss of between 0.0925 yuan and 0.1233 yuan, compared to a loss of 0.1544 yuan per share last year [1] Reasons for Performance Change - The decrease in loss is attributed to cost reduction and efficiency improvement measures implemented by the company, along with a reduction in market development expenses due to the implementation of industry policies [1] - The company reported an increase in investment income from trading financial assets compared to the previous year, which contributed to the performance improvement [2]